Published in Int J Clin Rheumtol on April 01, 2012
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med (2015) 0.97
Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review. Ther Clin Risk Manag (2014) 0.85
Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus. Lupus (2016) 0.78
How do women with lupus manage fatigue? A focus group study. Clin Rheumatol (2016) 0.77
Pattern of initial clinical manifestations of systemic lupus erythematosus in a tertiary care hospital. Pak J Med Sci (2016) 0.75
Relationship between Changes in Fatigue and Exercise by Follow-Up Period. Korean J Fam Med (2016) 0.75
Is frailty a relevant concept in SLE? Lupus Sci Med (2017) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
Development of a fatigue scale. J Psychosom Res (1993) 10.16
The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res (1995) 9.99
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest (1995) 9.59
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med (2008) 9.50
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet (2011) 8.89
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85
The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol (1982) 5.78
The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes (2003) 5.24
Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 4.16
AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum (1992) 4.08
Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum (1980) 3.80
The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum (1998) 2.92
Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol (2005) 2.81
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus (2000) 2.81
Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology (2002) 2.68
Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr (2002) 2.38
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood (2000) 2.31
Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev (2005) 2.25
Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation (2004) 2.16
The measurement of fatigue: a new instrument. J Psychosom Res (1993) 2.05
Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum (1996) 1.88
Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.80
Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res (1993) 1.76
Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) (2008) 1.74
Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab (1998) 1.70
Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol (2006) 1.64
Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum (2007) 1.62
Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol (2003) 1.58
Defining and measuring fatigue. Image J Nurs Sch (1999) 1.57
Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus. J Rheumatol (2002) 1.49
Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum (2009) 1.48
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46
Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine (1991) 1.40
Genetics of systemic lupus erythematosus. Lupus (1995) 1.40
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus (2000) 1.37
Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol (1995) 1.36
High expression of complement components in omental adipose tissue in obese men. Obes Res (2003) 1.34
The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res (2007) 1.33
Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum (2003) 1.33
The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) (2000) 1.25
Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford) (2008) 1.24
A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum (2004) 1.21
Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol (1997) 1.18
Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res (1991) 1.16
A study of fatigue in systemic lupus erythematosus. J Rheumatol (1990) 1.13
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther (2008) 1.12
Quality of social support and associated social and psychological functioning in women with rheumatoid arthritis. Health Psychol (1990) 1.11
The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. J Clin Rheumatol (2007) 1.09
The validity and reliability of the fatigue syndrome that follows glandular fever. Psychol Med (1995) 1.07
Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum (2008) 1.07
Health outcome improvements in patients with systemic lupus erythematosus using two telephone counseling interventions. Arthritis Care Res (1996) 1.07
Current topics in human SLE genetics. Springer Semin Immunopathol (2006) 1.06
Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. Rheumatology (Oxford) (2004) 1.05
Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol (2002) 1.03
The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol (2001) 1.02
Fatigue in lupus is not correlated with disease activity. J Rheumatol (1998) 1.02
Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum (1998) 1.02
Fatigue in rheumatoid arthritis. Conditions, strategies, and consequences. Arthritis Care Res (1990) 1.02
The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc (1997) 1.01
Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) (2010) 1.01
Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol (1987) 1.00
Cellular and molecular mechanisms of regulation of autoantibody production in lupus. Ann N Y Acad Sci (2005) 0.99
Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum (2009) 0.98
Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol (2005) 0.98
Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum (2005) 0.97
Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. Res Nurs Health (1997) 0.95
The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol (2009) 0.94
The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis Rheum (1995) 0.94
Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: a pilot study. Lupus (2011) 0.94
Impact of disease activity and cumulative damage on the health of lupus patients. Lupus (1998) 0.94
Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J Rheumatol (2006) 0.93
Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 0.92
Work disability in systemic lupus erythematosus. Arthritis Rheum (2009) 0.91
Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis (1999) 0.90
Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis Rheum (1999) 0.90
Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors. J Rheumatol (2006) 0.90
Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol (1993) 0.89
Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2011) 0.89
Evidence for aerobic insufficiency in women with systemic Lupus erythematosus. Arthritis Rheum (2003) 0.89
Effects of aerobic conditioning in lupus fatigue: a pilot study. Br J Rheumatol (1989) 0.88
Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment. J Hepatol (1990) 0.88
Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum (2008) 0.88
Impact of obesity on functioning among women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2011) 0.86
Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum (2005) 0.86
Acupuncture for systemic lupus erythematosus: a pilot RCT feasibility and safety study. Lupus (2008) 0.86
Perceptions and measurements of physical activity in patients with systemic lupus erythematosus. Lupus (2010) 0.85
A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res (2000) 0.84
Disease status predicts fatigue in systemic lupus erythematosus. J Rheumatol (2001) 0.83
Fatigue in systemic lupus erythematosus and rheumatoid arthritis. PM R (2010) 0.83
Pituitary hormones and systemic lupus erythematosus. Arthritis Rheum (2005) 0.82
Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry (2007) 0.82
The problem of fatigue in dialysis patients. Nephron (1982) 0.81
Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus. Lupus (2004) 0.81
Chronic fatigue syndrome--a controlled cross sectional study. J Rheumatol (1994) 0.81
Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. J Rheumatol (2002) 0.81
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) (2012) 6.51
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet (2009) 5.75
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum (2013) 4.02
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet (2011) 2.54
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2009) 2.31
US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum (2003) 2.21
Cancer screening in patients with systemic lupus erythematosus. J Rheumatol (2005) 1.75
Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr (2006) 1.71
Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum (2008) 1.64
Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol (2007) 1.63
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol (2014) 1.62
History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum (2005) 1.58
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun (2013) 1.47
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum (2009) 1.43
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet (2010) 1.43
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis (2011) 1.41
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis (2011) 1.38
Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med (2006) 1.34
A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum (2009) 1.23
25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum (2009) 1.20
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum (2011) 1.19
Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet (2008) 1.16
Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet (2013) 1.14
Malignancy and autoimmunity. Curr Opin Rheumatol (2006) 1.11
The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol (2002) 1.10
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis (2009) 1.08
The role of genetic variation near interferon-kappa in systemic lupus erythematosus. J Biomed Biotechnol (2010) 1.07
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis (2012) 1.07
Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Ann Rheum Dis (2011) 1.06
Malignancies in juvenile idiopathic arthritis: a preliminary report. J Rheumatol (2011) 1.04
Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis (2013) 1.03
Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis (2012) 1.02
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum (2012) 1.01
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum (2004) 1.01
Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus. Arthritis Rheum (2011) 1.01
MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet (2013) 0.99
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis Rheum (2012) 0.99
Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms. Autoimmun Rev (2005) 0.99
Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum (2011) 0.98
Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum (2012) 0.98
Association between African American race/ethnicity and low bone mineral density in women with systemic lupus erythematosus. Arthritis Rheum (2007) 0.97
The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol (2010) 0.97
Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis (2012) 0.96
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum (2012) 0.96
Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol (2002) 0.96
ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol (2013) 0.95
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum (2008) 0.94
Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum (2008) 0.94
Systemic lupus and malignancies. Curr Opin Rheumatol (2012) 0.94
PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS One (2013) 0.91
An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Jt Comm J Qual Patient Saf (2005) 0.91
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum (2011) 0.89
Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. PLoS Genet (2013) 0.89
Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res (2008) 0.88
Self-reported fractures and associated factors in women with systemic lupus erythematosus. J Rheumatol (2007) 0.87
Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus. Am J Cardiol (2013) 0.87
Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin North Am (2005) 0.87
Malignancy in systemic lupus erythematosus: what have we learned? Best Pract Res Clin Rheumatol (2009) 0.87
Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis. J Pediatr (2011) 0.87
Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis Care Res (Hoboken) (2010) 0.86
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis (2012) 0.86
Lymphoma in a patient with systemic lupus erythematosus. Nat Clin Pract Rheumatol (2006) 0.86
Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus. BMC Med Genet (2011) 0.85
Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis. Transplantation (2013) 0.85
Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumtol (2010) 0.85
Megakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigens. J Immunol (2012) 0.85
Genetic risk factors for thrombosis in systemic lupus erythematosus. J Rheumatol (2012) 0.85
Malignancies in systemic lupus erythematosus: a 2015 update. Curr Opin Rheumatol (2015) 0.84
Malignancies and cyclophosphamide exposure in Wegener's granulomatosis. J Rheumatol (2008) 0.84
Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis Rheum (2012) 0.84
Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology (2013) 0.83
Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes. J Rheumatol (2009) 0.83
Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators. Arthritis Care Res (Hoboken) (2011) 0.83
Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep (2002) 0.83
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken) (2014) 0.83
Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans. Arthritis Rheumatol (2014) 0.82
Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2014) 0.82
Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy. J Rheumatol (2008) 0.82
Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians. Arthritis Rheum (2013) 0.82
Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity. Clin Immunol (2013) 0.81
Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses. Sci Transl Med (2013) 0.81
Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. J Rheumatol (2008) 0.81
A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus. Arthritis Rheumatol (2014) 0.80
Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken) (2012) 0.80
Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus. J Rheumatol (2011) 0.80
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort. J Rheumatol (2014) 0.79
Do traditional Gail model risk factors account for increased breast cancer in women with lupus? J Rheumatol (2003) 0.79
Missed opportunities in physician management of glucocorticoid-induced osteoporosis? Arthritis Rheum (2002) 0.79
Genome-wide association study of antiphospholipid antibodies. Autoimmune Dis (2013) 0.78
Functional and genetic characterization of the promoter region of apolipoprotein H (beta2-glycoprotein I). FEBS J (2010) 0.78
Self-reported and objectively measured physical activity in adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2015) 0.78
Bone health and systemic lupus erythematosus. Curr Rheumatol Rep (2005) 0.78
Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. J Rheumatol (2013) 0.78
Revisiting the issue of malignancy risk in systemic lupus erythematosus. Curr Rheumatol Rep (2005) 0.77
Editorial: Updates in US systemic lupus erythematosus epidemiology: Tales of two cities. Arthritis Rheumatol (2014) 0.77